From: Real-world experience comparing two common left atrial appendage closure devices
Watchman™ (clinical follow up: n = 112; TOE follow-up: n = 102) | Amplatzer™ Amulet™ (clinical follow-up: n = 30; TOE follow-up: n = 21) | p value* | OR (95% CI) | |
---|---|---|---|---|
Device detectable in LAA, n (%) | 102 (100.0) | 21 (100.0) | 1.00 | – |
Peri-device leak < 5 mm, n (%) | 14 (13.7) | 2 (9.5) | 1.00 | 0.66 (0.13–3.16) |
Peri-device leak > 5 mm, n (%) | 1 (1.0) | 0 (0.0) | 1.00 | – |
Device thrombus, n (%) | 4 (4.9) | 0 (0.0) | 0.59 | 0.51 (0.02–9.82) |
Pericardial effusion, n (%) | 2 (2.0) | 0 (0.0) | 1.00 | – |
Minor bleeding, n (%) | 4 (3.6) | 1 (3.3) | 1.00 | 1.07 (0.11–6.24) |
Major bleeding, n (%) | 6 (5.4) | 2 (6.7) | 0.68 | 0.79 (0.13–6.04) |
Thromboembolic event, n (%) | 1 (0.9) | 0 (0.0) | 1.00 | 1.22 (0.04–30.70) |
Death, n (%) | 4 (3.6) | 2 (6.7) | 0.61 | 1.93 (0.33–11.08) |